238 related articles for article (PubMed ID: 35917099)
1. Gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs): a radiomic model to predict tumor grade.
Chiti G; Grazzini G; Flammia F; Matteuzzi B; Tortoli P; Bettarini S; Pasqualini E; Granata V; Busoni S; Messserini L; Pradella S; Massi D; Miele V
Radiol Med; 2022 Sep; 127(9):928-938. PubMed ID: 35917099
[TBL] [Abstract][Full Text] [Related]
2. Prediction of the characteristics of aggressiveness of pancreatic neuroendocrine neoplasms (PanNENs) based on CT radiomic features.
Mori M; Palumbo D; Muffatti F; Partelli S; Mushtaq J; Andreasi V; Prato F; Ubeira MG; Palazzo G; Falconi M; Fiorino C; De Cobelli F
Eur Radiol; 2023 Jun; 33(6):4412-4421. PubMed ID: 36547673
[TBL] [Abstract][Full Text] [Related]
3. Neuroendocrine Tumor Heterogeneity Adds Uncertainty to the World Health Organization 2010 Classification: Real-World Data from the Spanish Tumor Registry (R-GETNE).
Nuñez-Valdovinos B; Carmona-Bayonas A; Jimenez-Fonseca P; Capdevila J; Castaño-Pascual Á; Benavent M; Pi Barrio JJ; Teule A; Alonso V; Custodio A; Marazuela M; Segura Á; Beguiristain A; Llanos M; Martinez Del Prado MP; Diaz-Perez JA; Castellano D; Sevilla I; Lopez C; Alonso T; Garcia-Carbonero R
Oncologist; 2018 Apr; 23(4):422-432. PubMed ID: 29330208
[TBL] [Abstract][Full Text] [Related]
4. CT radiomics may predict the grade of pancreatic neuroendocrine tumors: a multicenter study.
Gu D; Hu Y; Ding H; Wei J; Chen K; Liu H; Zeng M; Tian J
Eur Radiol; 2019 Dec; 29(12):6880-6890. PubMed ID: 31227882
[TBL] [Abstract][Full Text] [Related]
5. The Correlation Between [
Yu J; Li N; Li J; Lu M; Leal JP; Tan H; Su H; Fan Y; Zhang Y; Zhao W; Zhu H; Pomper MG; Zhou Y; Yang Z
Mol Imaging Biol; 2019 Oct; 21(5):984-990. PubMed ID: 30796708
[TBL] [Abstract][Full Text] [Related]
6. Accurate non-invasive grading of nonfunctional pancreatic neuroendocrine tumors with a CT derived radiomics signature.
Javed AA; Zhu Z; Kinny-Köster B; Habib JR; Kawamoto S; Hruban RH; Fishman EK; Wolfgang CL; He J; Chu LC
Diagn Interv Imaging; 2024 Jan; 105(1):33-39. PubMed ID: 37598013
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathological features and prognosis of gastroenteropancreatic neuroendocrine neoplasms in a Chinese population: a large, retrospective single-centre study.
Zhang M; Zhao P; Shi X; Zhao A; Zhang L; Zhou L
BMC Endocr Disord; 2017 Jul; 17(1):39. PubMed ID: 28705205
[TBL] [Abstract][Full Text] [Related]
8. CT-Radiomic Approach to Predict G1/2 Nonfunctional Pancreatic Neuroendocrine Tumor.
Zhao Z; Bian Y; Jiang H; Fang X; Li J; Cao K; Ma C; Wang L; Zheng J; Yue X; Zhang H; Wang X; Madabhushi A; Xu J; Jin G; Lu J
Acad Radiol; 2020 Dec; 27(12):e272-e281. PubMed ID: 32037260
[TBL] [Abstract][Full Text] [Related]
9. Usefulness of texture analysis for grading pancreatic neuroendocrine tumors on contrast-enhanced computed tomography and apparent diffusion coefficient maps.
Ohki K; Igarashi T; Ashida H; Takenaga S; Shiraishi M; Nozawa Y; Ojiri H
Jpn J Radiol; 2021 Jan; 39(1):66-75. PubMed ID: 32885378
[TBL] [Abstract][Full Text] [Related]
10. [Pathological characteristics and survival analysis of 355 patients with gastroenteropancreatic neuroendocrine neoplasms].
Li Y; Wang YF; Tan BB; Er LM; Zhao Q; Fan LQ; Zhang ZD; Liu Y
Zhonghua Zhong Liu Za Zhi; 2020 May; 42(5):426-431. PubMed ID: 32482035
[No Abstract] [Full Text] [Related]
11. CT-based radiomics for prediction of therapeutic response to Everolimus in metastatic neuroendocrine tumors.
Caruso D; Polici M; Rinzivillo M; Zerunian M; Nacci I; Marasco M; Magi L; Tarallo M; Gargiulo S; Iannicelli E; Annibale B; Laghi A; Panzuto F
Radiol Med; 2022 Jul; 127(7):691-701. PubMed ID: 35717429
[TBL] [Abstract][Full Text] [Related]
12. Utility of CT in differentiating liver metastases of well-differentiated gastroenteropancreatic neuroendocrine neoplasms from poorly-differentiated neuroendocrine neoplasms.
Cui Y; Li X; Gao S; Li Z; Li Y; Lu M; Sun Y
Chin J Cancer Res; 2018 Feb; 30(1):31-39. PubMed ID: 29545717
[TBL] [Abstract][Full Text] [Related]
13. Expression and clinical value of CXCR4 in high grade gastroenteropancreatic neuroendocrine neoplasms.
Pang C; Li Y; Shi M; Fan Z; Gao X; Meng Y; Liu S; Gao C; Su P; Wang X; Zhan H
Front Endocrinol (Lausanne); 2024; 15():1281622. PubMed ID: 38524630
[TBL] [Abstract][Full Text] [Related]
14. Correlation of World Health Organization 2010 Classification for Gastroenteropancreatic Neuroendocrine Neoplasms with the Prognosis of Ovarian Neuroendocrine Neoplasms: Kansai Clinical Oncology Group-Protocol Review Committee/Intergroup Study.
Kai K; Nasu K; Nishida H; Daa T; Shikama A; Shiozaki T; Kurakazu M; Yano M; Imamura Y; Tokunaga H; Tasaki K; Iida Y; Yamada Y; Morisawa H; Nakagawa S; Fujimoto E; Tsuruta T; Matsumoto H; Arakawa A; Nonaka M; Takano H; Ushiwaka T; Mori T; Ito K; Motohashi T; Teramoto N; Yamada T
Neuroendocrinology; 2021; 111(4):320-329. PubMed ID: 32097950
[TBL] [Abstract][Full Text] [Related]
15. An update on the diagnosis of gastroenteropancreatic neuroendocrine neoplasms.
Fang JM; Li J; Shi J
World J Gastroenterol; 2022 Mar; 28(10):1009-1023. PubMed ID: 35431496
[TBL] [Abstract][Full Text] [Related]
16. CT-derived radiomic features to discriminate histologic characteristics of pancreatic neuroendocrine tumors.
Benedetti G; Mori M; Panzeri MM; Barbera M; Palumbo D; Sini C; Muffatti F; Andreasi V; Steidler S; Doglioni C; Partelli S; Manzoni M; Falconi M; Fiorino C; De Cobelli F
Radiol Med; 2021 Jun; 126(6):745-760. PubMed ID: 33523367
[TBL] [Abstract][Full Text] [Related]
17. New frontiers in imaging including radiomics updates for pancreatic neuroendocrine neoplasms.
Saleh M; Bhosale PR; Yano M; Itani M; Elsayes AK; Halperin D; Bergsland EK; Morani AC
Abdom Radiol (NY); 2022 Sep; 47(9):3078-3100. PubMed ID: 33095312
[TBL] [Abstract][Full Text] [Related]
18. Multiphase computed tomography radiomics of pancreatic intraductal papillary mucinous neoplasms to predict malignancy.
Polk SL; Choi JW; McGettigan MJ; Rose T; Ahmed A; Kim J; Jiang K; Balagurunathan Y; Qi J; Farah PT; Rathi A; Permuth JB; Jeong D
World J Gastroenterol; 2020 Jun; 26(24):3458-3471. PubMed ID: 32655269
[TBL] [Abstract][Full Text] [Related]
19. Preoperative Prediction of G1 and G2/3 Grades in Patients With Nonfunctional Pancreatic Neuroendocrine Tumors Using Multimodality Imaging.
Liu C; Bian Y; Meng Y; Liu F; Cao K; Zhang H; Fang X; Li J; Yu J; Feng X; Ma C; Lu J; Xu J; Shao C
Acad Radiol; 2022 Apr; 29(4):e49-e60. PubMed ID: 34175209
[TBL] [Abstract][Full Text] [Related]
20. Prediction of the World Health Organization Grade of rectal neuroendocrine tumors based on CT histogram analysis.
Liang P; Xu C; Tan F; Li S; Chen M; Hu D; Kamel I; Duan Y; Li Z
Cancer Med; 2021 Jan; 10(2):595-604. PubMed ID: 33263225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
